🔎 Trials Near Me

Akèy › Migrèn › Florid › Orlando

Etid klinik pou Migrèn nan Orlando, FL

6 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of EVO756 in Adults With Migraine

Ap rekriteFaz 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07616128

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Clinical Associates of Orlando, LLC, Orlando
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Ap rekriteFaz 3
  • Clinical Associates of Orlando, LLC, Orlando
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Ap rekriteFaz 3
  • Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263, Winter Park · 5 mi lwen
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Ap rekriteFaz 3
  • Clinical Associates of Orlando, LLC /ID# 272619, Orlando
  • Pediatric Neurology and Epilepsy Specialists /ID# 229967, Winter Park · 5 mi lwen
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

Ap rekriteFaz 2
  • Clinical Neuroscineces Solutions - Orlando, Orlando
  • Clinical Neuroscineces Solutions, Orlando
Laj 18 a 65 · Tout sèks · Mizajou Sep 2, 2026 · NCT07646613

Etid Migrèn nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.